Q&A: Expert discusses risks of cannabis use

Article excerpt

In April, the federal government reclassified cannabis from Schedule I to Schedule III, acknowledging medical applications and lower abuse potential. An expert discusses the substance's risks in a Q&A format, examining health impacts alongside the policy shift that reflects evolving scientific and medical understanding of cannabis. The reclassification represents a significant reversal in federal drug policy, moving away from the blanket prohibition that had classified cannabis as having no legitimate medical uses.